NYRA

"Making neurological therapy accessible to everyone through innovative, evidence-based solutions."

Where it wins

• Clinical efficacy: 93% stronger improvement in language and cognition skills compared to standard therapy, validated in a 12-week randomised controlled trial [1].
• Seamless continuity of care: Bridges the gap between inpatient rehabilitation and home life, addressing the critical drop-off in patient progress post-discharge [2].
• Insurance-backed accessibility: Costs covered by partner health insurance companies (public and private), making the therapy free for patients and removing financial barriers [1].
• Clinician efficiency: Reduces administrative burden on therapy teams while providing measurable, data-driven progress tracking for clinicians [1].

Credibility: Results from a 12-week randomised controlled trial on AI-based neurorehabilitation and user satisfaction data from the German pension insurance (DRV) aftercare program [1].

• Digital therapy ecosystem: Combines a CE-certified mobile app (myReha) with a clinic management platform (nyra insights) and upcoming content tools (Content Studio) [1].
• Evidence-based AI: Uses machine learning to personalize therapy plans based on patient progress, ensuring clinical efficacy and engagement [2].
• Insurance integration: Partners with health insurance companies to cover therapy costs, creating a sustainable revenue stream and removing patient friction [1].
• Scalable delivery: Delivers therapy via smartphones and tablets, allowing treatment to scale beyond clinic walls into patients' homes [1].

• Traditional therapy providers: Offer in-person therapy but lack scalability and data-driven personalization [1].
• Digital health apps: Many apps lack clinical validation, CE certification, and insurance coverage [1].
• Rehabilitation software: Existing solutions often focus on administration rather than personalized, evidence-based therapy [1].
• Differentiators: nyra.health combines CE certification, clinical efficacy, insurance coverage, and AI personalization, creating a unique value proposition [1].
• Threats: Entry of well-funded digital health competitors or changes in insurance reimbursement policies [1].

• Fragmented care: Patients struggle to maintain therapy progress after discharge from inpatient rehabilitation [2].
• Staff shortages: Therapy teams are overburdened, limiting the time available for personalized patient care [2].
• Limited access: Effective neurological therapy is often inaccessible due to cost, location, or availability of specialists [2].
• Lack of measurable progress: Clinicians lack data-driven insights to track and demonstrate patient improvement [1].
• High long-term costs: Inadequate aftercare leads to higher long-term care expenses for insurance providers and society [2].

nyra.health's insurance-backed model creates a strong moat by aligning patient access with payer incentives. The main risk is regulatory changes in digital health reimbursement. The opportunity lies in expanding into adjacent neurological conditions and international markets. The next signal to watch is the adoption rate among private practices and the results of ongoing clinical trials.

Expand marketing efforts to directly target patients through digital channels to increase app downloads and insurance claims. Interpration: Develop a robust referral system for clinics to easily integrate myReha into their discharge planning workflows. Publish more clinical studies to strengthen the evidence base and attract additional insurance partners. Enhance the Content Studio to allow clinics and practices to create custom therapy content, increasing platform stickiness.